78 related articles for article (PubMed ID: 8061141)
1. [Progressive multifocal leukoencephalopathy and AIDS. Response to cytarabine].
Hervas Laguna MJ; Nieto Rodríguez JA; Geijo Martínez MP; Ruiz Ribo MD; Borregón S
An Med Interna; 1994 May; 11(5):241-3. PubMed ID: 8061141
[TBL] [Abstract][Full Text] [Related]
2. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
[TBL] [Abstract][Full Text] [Related]
3. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Gillini L; Murri R; Antinori A
Clin Infect Dis; 1999 Mar; 28(3):624-8. PubMed ID: 10194089
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside.
Guarino M; D'Alessandro R; Rinaldi R; Stracciari A; Pazzaglia P; Costigliola P; Marinacci G; Chiodo F; Di Giandomenico G; Cancellieri C
AIDS; 1995 Jul; 9(7):819-20. PubMed ID: 7546435
[No Abstract] [Full Text] [Related]
5. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon.
Steiger MJ; Tarnesby G; Gabe S; McLaughlin J; Schapira AH
Ann Neurol; 1993 Apr; 33(4):407-11. PubMed ID: 7683856
[TBL] [Abstract][Full Text] [Related]
6. Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS.
Moreno S; Miralles P; Díaz MD; Berenguer J; Bernaldo de Quirós JC; Blázquez R; Cosín J; Bouza E
Clin Infect Dis; 1996 Nov; 23(5):1066-8. PubMed ID: 8922804
[TBL] [Abstract][Full Text] [Related]
7. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
[No Abstract] [Full Text] [Related]
8. Cytarabine nixed for PML.
GMHC Treat Issues; 1996 Nov; 10(11):9. PubMed ID: 11364014
[TBL] [Abstract][Full Text] [Related]
9. PML--update.
Crit Path AIDS Proj; 1994-1995 Winter; (No 30):28-9. PubMed ID: 11362157
[TBL] [Abstract][Full Text] [Related]
10. Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia.
Hequet O; Salles G; Espinousse D; Dumontet C; Bouafia F; Thieblemont C; Revesz D; Coiffier B
Ann Hematol; 2002 Jun; 81(6):340-2. PubMed ID: 12107566
[TBL] [Abstract][Full Text] [Related]
11. [A case of progressive multifocal leukoencephalopathy in AIDS: neuroimaging with clinical and pathologic correlation].
Feydy A; Carlier R; Gray F; Bernard L; Mutschler C; Laure R; Vallée C
J Radiol; 2000 Mar; 81(3):233-6. PubMed ID: 10740072
[TBL] [Abstract][Full Text] [Related]
12. Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal study.
Eggers C; Stellbrink HJ; Buhk T; Dörries K
J Infect Dis; 1999 Nov; 180(5):1690-4. PubMed ID: 10515834
[TBL] [Abstract][Full Text] [Related]
13. Akinetic-rigid syndrome in a 13-year-old girl with HIV-related progressive multifocal leukoencephalopathy.
Singer C; Berger JR; Bowen BC; Bruce JH; Weiner WJ
Mov Disord; 1993; 8(1):113-6. PubMed ID: 8419794
[TBL] [Abstract][Full Text] [Related]
14. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
[TBL] [Abstract][Full Text] [Related]
15. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
[TBL] [Abstract][Full Text] [Related]
16. Topotecan and PML: the limits of pharmaceutical industry research.
Learned J
Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy (PML).
Proj Inf Perspect; 1998 Apr; (24):23-4. PubMed ID: 11365717
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy.
D'Amico R; Sarkar S; Yusuff J; Azar E; Perlman DC
Scand J Infect Dis; 2007; 39(4):347-50. PubMed ID: 17454900
[TBL] [Abstract][Full Text] [Related]
19. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
[TBL] [Abstract][Full Text] [Related]
20. [Progressive multifocal leukoencephalopathy in elderly immunocompetent patients. Report of 2 cases].
Bosch J; Sumalla J; Mauleón A; Rovira A; Molins M; Acarín N
Rev Neurol; 1999 Jul 16-31; 29(2):133-7. PubMed ID: 10528326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
